ArticleBMJ global health2025
Who's leading WHO? A quantitative analysis of the Bill and Melinda Gates Foundation's grants to WHO, 2000-2024.
Article in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe Bill and Melinda Gates Foundation (BMGF) has been the World Health Organization's (WHO) second biggest source of funding in recent years, contributing 9.5% of WHO's revenues between 2010 and 2023 through voluntary contributions. It is widely assumed that BMGF's financial power allows it to exert considerable influence over WHO. However, very little empirical research has been undertaken into the BMGF-WHO relationship. Our study investigates how the money that BMGF gives to WHO is spent.
methodsWe constructed a dataset of BMGF grants to WHO for the period 2000-2024 by extracting and coding data retrieved from BMGF's website. The dataset was analysed to examine the number and value of grants, and the diseases or health issues and activities that were funded.
resultsBMGF made 640 grants worth $5.5 billion to WHO between 2000 and 2024. This is 6.4% of all BMGF's grants by value in the period. Grants worth $4.5 billion focused on infectious diseases. This amounts to 82.6% of all BMGF contributions to WHO by value. Of these, $3.2 billion (58.9%) went to polio. $2.9 billion - 53.3% of the money BMGF disbursed to WHO - funded vaccine programmes and projects. Relatively little BMGF funding went to non-communicable diseases, strengthening health systems, and broader determinants of health, despite their importance to WHO strategy and global health more generally.
conclusionWHO's reliance on earmarked voluntary contributions means that global health challenges favoured by major donors' are well funded while other issues receive insufficient funding. As one of WHO's biggest donors, BMGF contributes to this problem by pursuing its narrow approach to global public health - one that focuses on technical solutions to infectious diseases - through WHO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.